Humoral and Cellular Immune Response 26 months [clinicaltrials_resource:9c05cc9aede01c1c4ceb71f3ed871e2d]
Number of patients that developed a delayed-type hypersensitivity (DTH) response at following vaccination. Any skin reaction in response to the intradermal injection of the antigen was measured and recorded. A positive skin test was defined as > 5 mm induration (swelling).
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Humoral and Cellular Immune Response 26 months [clinicaltrials_resource:9c05cc9aede01c1c4ceb71f3ed871e2d]
Number of patients that developed a delayed-type hypersensitivity (DTH) response at following vaccination. Any skin reaction in response to the intradermal injection of the antigen was measured and recorded. A positive skin test was defined as > 5 mm induration (swelling).
Bio2RDF identifier
9c05cc9aede01c1c4ceb71f3ed871e2d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9c05cc9aede01c1c4ceb71f3ed871e2d
measure [clinicaltrials_vocabulary:measure]
Humoral and Cellular Immune Response
time frame [clinicaltrials_vocabulary:time-frame]
description
Number of patients that develo ...... > 5 mm induration (swelling).
identifier
clinicaltrials_resource:9c05cc9aede01c1c4ceb71f3ed871e2d
title
Humoral and Cellular Immune Response 26 months
@en
type
label
Humoral and Cellular Immune Re ...... 5cc9aede01c1c4ceb71f3ed871e2d]
@en